85
59
Growth Score
-3 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
349202
Contera Pharma identifies and develops innovative treatments for patients suffering from movement disorders
Mikael Thomsen: Founder, CSO
Bukwang Pharmaceutical Co
About the Company
Contera Pharma identifies and develops innovative treatments for patients suffering from movement disorders. They use their expertise in drug discovery and development in close collaboration with expert individuals and organizations to provide foundations for success.
The lead project JM-010 is approved for Phase IIa clinical trials for
treatment of dyskinesia associated with Parkinson's disease.
